DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$224.39
−2.03%Forward multiples
Based on analyst estimates
- P/E forward
- 24.77x
- P/E 2026E
- 26.40x
- P/E 2027E
- 24.15x
- P/E 2028E
- 21.95x
- P/S forward
- 5.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- 39.72x
- PEG TTM
- 0.66x
- Price / book
- 3.00x
- Price / sales
- 6.28x
- Price / cash flow
- 23.77x
Enterprise value
- Enterprise value
- $180.0B
- EV / sales
- 7.17x
- EV / EBITDA
- 23.73x
- EV / EBIT
- 35.10x
- Market cap
- $157.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026